Ngā hua rapu - Altschuh, Danièle

  • E whakaatu ana i te 1 - 6 hua o te 6
Whakamahine hua
  1. 1
    Functional aspects of co-variant surface charges in an antibody fragment

    Functional aspects of co-variant surface charges in an antibody fragment mā Hugo, Nicolas, Lafont, Virginie, Beukes, Mervyn, Altschuh, Danièle

    I whakaputaina 2002
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Dissecting the oligonucleotide binding properties of a disordered chaperone protein using surface plasmon resonance

    Dissecting the oligonucleotide binding properties of a disordered chaperone protein using surface plasmon resonance mā Baltzinger, Mireille, Sharma, Kamal Kant, Mély, Yves, Altschuh, Danièle

    I whakaputaina 2013
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    A Combinatorial Approach for the Design of Complementarity-determining Region-derived Peptidomimetics with in Vitro Anti-tumoral Activity

    A Combinatorial Approach for the Design of Complementarity-determining Region-derived Peptidomimetics with in Vitro Anti-tumoral Activity mā Timmerman, Peter, Barderas, Rodrigo, Desmet, Johan, Altschuh, Danièle, Shochat, Susana, Hollestelle, Martine J., Höppener, Jo W. M., Monasterio, Alberto, Casal, J. Ignacio, Meloen, Rob H.

    I whakaputaina 2009
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Targeted vaccination against the bevacizumab binding site on VEGF using 3D-structured peptides elicits efficient antitumor activity

    Targeted vaccination against the bevacizumab binding site on VEGF using 3D-structured peptides elicits efficient antitumor activity mā Wentink, Madelon Q., Hackeng, Tilman M., Tabruyn, Sebastien P., Puijk, Wouter C., Schwamborn, Klaus, Altschuh, Daniele, Meloen, Rob H., Schuurman, Teun, Griffioen, Arjan W., Timmerman, Peter

    I whakaputaina 2016
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Relationship between the agonist activity of synthetic ligands of TRAIL-R2 and their cell surface binding modes

    Relationship between the agonist activity of synthetic ligands of TRAIL-R2 and their cell surface binding modes mā Chekkat, Neila, Lombardo, Caterina M., Seguin, Cendrine, Lechner, Marie-Charlotte, Dufour, Florent, Nominé, Yves, De Giorgi, Marcella, Frisch, Benoit, Micheau, Olivier, Guichard, Gilles, Altschuh, Danièle, Fournel, Sylvie

    I whakaputaina 2018
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    High-Risk Mucosal Human Papillomavirus 16 (HPV16) E6 Protein and Cutaneous HPV5 and HPV8 E6 Proteins Employ Distinct Strategies To Interfere with Interferon Regulatory Factor 3-Mediated Beta Interferon Expression

    High-Risk Mucosal Human Papillomavirus 16 (HPV16) E6 Protein and Cutaneous HPV5 and HPV8 E6 Proteins Employ Distinct Strategies To Interfere with Interferon Regulatory Factor 3-Med... mā Poirson, Juline, Suarez, Irina Paula, Straub, Marie-Laure, Cousido-Siah, Alexandra, Peixoto, Paul, Hervouet, Eric, Foster, Anne, Mitschler, André, Mukobo, Noella, Chebaro, Yassmine, Garcin, Dominique, Recberlik, Sevda, Gaiddon, Christian, Altschuh, Danièle, Nominé, Yves, Podjarny, Alberto, Trave, Gilles, Masson, Murielle

    I whakaputaina 2022
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: